S
Cameron Durrant
WW VP, Global Strategic Marketing, Virology, J&J
YOU DIDN'T KNOW: While working as a physician, he opened a men's clothing company
Declaring a weakness is actually a strength." "You acquire more power by giving it up." Paradoxes like these are Cameron Durrant's stock-in-trade—visionary thinking about new leadership in pharma. "Tradition can be torn up," he says. "We can reinvent how we deliver value."
Cameron Durrant
Durrant's background is anything but traditional. "I grew up in pretty deprived circumstances," he recalls. "The school I went to—no one had gone to medical school before. 'It's just not possible,' I was told at 13." He took this as a challenge—and ultimately become an MD. "I see adversity as an opportunity to be resilient."
This preparation is perfect training to lead an industry facing unprecedented adversity. Currently running J&J's global strategic marketing for its virology portfolio (including HIV, hep C, and TB), Durrant is keen on creating "new healthcare partnerships, philanthropic models, ways of bringing information to customers."
He added business brains to his own portfolio by starting a medical devices company and heading strategic development at Pharmacia, among other jobs. This range has given Durrant a unique view on the industry's pitfalls and potentials. The only constant, he says, is change. The way forward is "servant leadership, greater transparency, [plus everything from] safe environments for employees to exquisite levels of service solutions for customers."
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.